{"acute leukaemia": 16.79, "acute myeloid leukaemia": 28.88, "adverse drug reaction": 2.98, "anaemia": 43.37, "ascites": 4.75, "blood creatinine increased": 3.74, "blood test abnormal": 3.38, "breast cancer": 2.33, "carbohydrate antigen 125 increased": 309.14, "creatinine renal clearance decreased": 5.31, "decreased appetite": 2.4, "disease progression": 3.24, "drug intolerance": 2.67, "dyspepsia": 2.64, "dysphagia": 2.07, "erythema nodosum": 4.09, "feeding disorder": 2.45, "full blood count abnormal": 3.83, "gastrointestinal disorder": 2.32, "glomerular filtration rate decreased": 3.32, "haematocrit decreased": 2.36, "haematotoxicity": 20.19, "haemoglobin decreased": 9.34, "hypophagia": 2.08, "ileus": 19.29, "intentional product misuse": 3.25, "interstitial lung disease": 8.33, "intestinal obstruction": 5.01, "laboratory test abnormal": 3.37, "leukaemia": 9.56, "leukopenia": 3.45, "malignant neoplasm progression": 17.12, "metastases to bone": 6.08, "metastases to central nervous system": 12.71, "metastases to liver": 6.53, "metastases to lung": 3.5, "metastases to lymph nodes": 11.05, "metastases to meninges": 8.91, "metastases to peritoneum": 33.78, "metastasis": 20.41, "myelodysplastic syndrome": 68.16, "myelosuppression": 5.86, "nausea": 2.27, "neoplasm": 4.78, "neutropenia": 3.98, "neutrophil count decreased": 19.2, "no adverse event": 6.95, "off label use": 3.15, "ovarian cancer": 18.56, "ovarian cancer recurrent": 837.66, "pancytopenia": 6.38, "platelet count decreased": 9.13, "pneumocystis jirovecii pneumonia": 3.3, "pneumonitis": 4.21, "product dose omission issue": 2.42, "product prescribing error": 2.65, "product use complaint": 9.29, "product use in unapproved indication": 3.45, "product use issue": 2.52, "prostatic specific antigen increased": 9.12, "recurrent cancer": 33.18, "red blood cell count decreased": 6.53, "renal impairment": 3.68, "stomatitis": 2.66, "taste disorder": 6.68, "thrombocytopenia": 5.6, "tumour marker increased": 44.29, "white blood cell count decreased": 4.81}